New York State Common Retirement Fund
CCCC icon

New York State Common Retirement Fund’s C4 Therapeutics CCCC Stock Holding History

New York State Common Retirement Fund’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$113K Buy
+24,100
New +$82.4K ﹤0.01% 2627
2025
Q2 		– Sell
-9,100
Closed -$14.6K – 3220
2025
Q1 		$14.6K Hold
9,100
– – ﹤0.01% 3024
2024
Q4 		$32.8K Hold
9,100
– – ﹤0.01% 2959
2024
Q3 		$51.9K Sell
9,100
-14,600
-62% -$87.9K ﹤0.01% 2853
2024
Q2 		$109K Buy
+23,700
New +$141K ﹤0.01% 2707
2023
Q3 		– Sell
-320
Closed -$880 – 3286
2023
Q2 		$880 Sell
320
-7,544
-96% -$24.2K ﹤0.01% 3322
2023
Q1 		$24.7K Sell
7,864
-20,738
-73% -$122K ﹤0.01% 3104
2022
Q4 		$169K Buy
28,602
+25
+0.1% +$207 ﹤0.01% 2796
2022
Q3 		$251K Buy
28,577
+125
+0.4% +$1.3K ﹤0.01% 2666
2022
Q2 		$215K Sell
28,452
-89
-0.3% -$783 ﹤0.01% 2767
2022
Q1 		$692K Buy
28,541
+18
+0.1% +$437 ﹤0.01% 2263
2021
Q4 		$918K Buy
28,523
+3,568
+14% +$141K ﹤0.01% 2139
2021
Q3 		$1.11M Sell
24,955
-4,626
-16% -$198K ﹤0.01% 2066
2021
Q2 		$1.12M Buy
29,581
+20,181
+215% +$723K ﹤0.01% 2174
2021
Q1 		$348K Buy
9,400
+1,600
+21% +$63.6K ﹤0.01% 2626
2020
Q4 		$258K Buy
+7,800
New +$226K ﹤0.01% 2640

Other funds holding CCCC

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $866M AUM 231.68% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $322M AUM
BCLSI
Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

New York State Common Retirement Fund's CCCC Position: Q2 2026 in Review

New York State Common Retirement Fund opened a new position in C4 Therapeutics (CCCC) in Q2 2026: 24,100 shares worth $113K. The stake represents ﹤0.01% of the portfolio and ranks #2627 among its holdings. This is a return to the name: New York State Common Retirement Fund previously reported a position in CCCC as recently as Q1 2025.

New York State Common Retirement Fund first reported a position in CCCC in Q4 2020 and has held it in 16 quarters since. The position peaked at $1.12M in Q2 2021. 147 funds tracked by Wall St. Rank hold CCCC as of Q2 2026.

  • New York State Common Retirement Fund held 24,100 shares of C4 Therapeutics worth $113K as of Q2 2026.
  • C4 Therapeutics was a new New York State Common Retirement Fund position in Q2 2026.
  • C4 Therapeutics made up ﹤0.01% of New York State Common Retirement Fund's portfolio in Q2 2026, its #2627 holding.
  • New York State Common Retirement Fund first reported a position in C4 Therapeutics in Q4 2020 and has held it in 16 quarters since.
  • New York State Common Retirement Fund's C4 Therapeutics position peaked at $1.12M in Q2 2021.
  • 147 funds tracked by Wall St. Rank held C4 Therapeutics as of Q2 2026.

Based on New York State Common Retirement Fund's 13F filing for Q2 2026, filed 29 Jul 2026.